Interventions to improve adherence in patients with immune-mediated inflammatory disorders: A systematic Review

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Depont, Fanny ^a   Berenbaum, Francis ^b   Filippi, Jerome ^c   Le Maitre, Michel ^d   Nataf, Henri ^e   Paul, Carle ^f   Peyrin Biroulet, Laurent ^g   Thibout, Emmanuel ^h  

^a SC Partners   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d Francois Quesnay Hospital ^*  (France)

^e Francois Quesnay Hospital   (France)

^f UNIVERSITÉ PAUL SABATIER   (France)

^g UNIVERSITÉ DE LORRAINE   (France)

^h ABBVIE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR THERAPY; COGNITIVE THERAPY; HUMAN; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; MEDICATION COMPLIANCE; MULTIPLE SCLEROSIS; PATIENT EDUCATION; PSORIASIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; ARTHRITIS, RHEUMATOID; INFLAMMATORY BOWEL DISEASES; META ANALYSIS; PSYCHOLOGY;

ARTHRITIS, RHEUMATOID; HUMANS; INFLAMMATORY BOWEL DISEASES; MEDICATION ADHERENCE; MULTIPLE SCLEROSIS; PSORIASIS;

EID: 84956636238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145076     Document Type: Review

References (37)

1. Williams JP, Meyers JA. Immune-mediated inflammatory disorders (I.M.I.D.s): The economic and clinical costs. Am J Manag Care. 2002; 8(21 Suppl):S664-81; quiz S82-5. Epub 2003/01/09. 144 [pii]. PMID: 12516953.
2. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: A review. Int J Clin Pract. 2008; 62(1):76-87. Epub 2007/11/07. IJCP1630 [pii] doi: 10.1111/j.1742-1241.2007.01630.x PMID: 17983433.
3. Makela MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013; 107(10):1481-90. Epub 2013/05/07. S0954-6111(13)00134-0 [pii] doi: 10.1016/j.rmed.2013.04.005 PMID: 23643487.
4. World Health Organization. Adherence to long-term therapies: Evidence for action Geneva. 2003. Available: Http://www.who.int/chp/knowledge/publications/adherence-report/en/.
5. Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA. Adherence in the treatment of psoriasis: A systematic review. Dermatology. 2011; 222(4):363-74. Epub 2011/07/16. 000329026 [pii] doi: 10.1159/000329026 PMID: 21757881.
6. Hill J. Adherence with drug therapy in the rheumatic diseases Part one: A review of adherence rates. Musculoskeletal Care. 2005; 3(2):61-73. Epub 2006/10/17. doi: 10.1002/msc.27 PMID: 17041995.
7. Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008; 53(4):1020-4. Epub 2007/10/16. doi: 10.1007/s10620-007-9968-0 PMID: 17934828.
8. Cook PF, Emiliozzi S, El-Hajj D, McCabe MM. Telephone nurse counseling for medication adherence in ulcerative colitis: A preliminary study. Patient Educ Couns. 2010; 81(2):182-6. Epub 2010/01/19. S0738-3991(09)00609-0 [pii] doi: 10.1016/j.pec.2009.12.010 PMID: 20079598.
9. Thorneloe RJ, Bundy C, Griffiths C, Ashcroft D, Cordingley L. Adherence to medication in patients with psoriasis: A systematic literature review. Bristish Journal of Dermatology. 2012; 168:20-31.
10. Homer D, Nightingale P, Jobanputra P. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction. Musculoskeletal Care. 2009; 7(2):78-92. Epub 2008/09/16. doi: 10.1002/msc. 141 PMID: 18792423.
11. Moshkovska T, Stone MA, Smith RM, Bankart J, Baker R, Mayberry JF. Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: Results from an exploratory randomized controlled trial. Inflamm Bowel Dis. 2011; 17(9):1874-81. Epub 2011/08/11. doi: 10.1002/ibd.21570 PMID: 21830265.
12. El Miedany Y, El Gaafary M, El Arousy N, Ahmed I, Youssef S, Palmer D. Arthritis education: The integration of patient-reported outcome measures and patient self-management. Clin Exp Rheumatol. 2012b; 30(6):899-904. Epub 2012/09/21. 5564 [pii]. PMID: 22992291.
13. Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, et al. E-health empowers patients with ulcerative colitis: A randomised controlled trial of the web-guided 'Constant-care' approach. Gut. 2010; 59(12):1652-61. Epub 2010/11/13. 59/12/1652 [pii] doi: 10.1136/gut.2010.220160 PMID: 21071584.
14. Moss AC, Chaudhary N, Tukey M, Junior J, Cury D, Falchuk KR, et al. Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis-a prospective study. J Crohns Colitis. 2010; 4(2):171-5. Epub 2010/12/03. S1873-9946(09)00107-X [pii] doi: 10.1016/j.crohns.2009.10. 002 PMID: 21122501.
15. Van Den Bemt BJ, Den Broeder AA, Van Den Hoogen FH, Benraad B, Hekster YA, Van Riel PL, et al. Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis. Scand J Rheumatol. 2011; 40(3):192-6. Epub 2010/10/28. doi: 10. 3109/03009742.2010.517214 PMID: 20977385.
16. Greenley RN, Kunz JH, Walter J, Hommel KA. Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis. 2013; 19(7):1534-45. Epub 2013/05/03 doi: 10.1097/MIB.0b013e3182813482 PMID: 23635715.
17. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009; 6(7):e1000100. Epub 2009/07/22. doi: 10.1371/journal. pmed.1000100 PMID: 19621070.
18. McGough JJ, Faraone SV. Estimating the size of treatment effects: Moving beyond p values. Psychiatry (Edgmont). 2009; 6(10):21-9. Epub 2009/12/17. PMID: 20011465.
19. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol. 2011; 64(4):407-15. Epub 2011/01/21. S0895-4356(10)00413-0 [pii] doi: 10.1016/j.jclinepi.2010.07.017 PMID: 21247734.
20. Anastats. Téléchargements d'utilitaires et d'exercices 2014. Available: Http://www.anastats.fr/stats/Telechargement.htm#puissance. Accessed: 2014 February 27.
21. Cross RK, Cheevers N, Rustgi A, Langenberg P, Finkelstein J. Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis. 2012; 18(6):1018-25. Epub 2011/06/21. doi: 10.1002/ibd.21795 PMID: 21688350.
22. Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: A randomized controlled trial. Can J Gastroenterol. 2005; 19(4):235-44. Epub 2005/04/30. PMID: 15861266.
23. Brus HL, Van De Laar MA, Taal E, Rasker JJ, Wiegman O. Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis. Ann Rheum Dis. 1998; 57(3):146-51. Epub 1998/06/26. PMID: 9640129.
24. El Miedany Y, El Gaafary M, Palmer D. Assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis patients: A pilot study. Rheumatol Int. 2012a; 32(10):3061-8. Epub 2011/09/13 doi: 10.1007/s00296-011-2098-1 PMID: 21909946.
25. Evers AW, Kraaimaat FW, Van Riel PL, De Jong AJ. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: A randomized controlled trial. Pain. 2002; 100(1-2):141-53. Epub 2002/11/19. S0304395902002749 [pii]. PMID: 12435467.
26. Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: A randomised controlled trial. Ann Rheum Dis. 2001; 60(9):869-75. Epub 2001/08/15. PMID: 11502614.
27. Balato N, Megna M, Di Costanzo L, Balato A, Ayala F. Educational and motivational support service: A pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol. 2013; 168 (1):201-5. Epub 2012/12/18. doi: 10.1111/j.1365-2133.2012.11205.x PMID: 23240729.
28. Berger BA, Liang H, Hudmon KS. Evaluation of software-based telephone counseling to enhance medication persistency among patients with multiple sclerosis. J Am Pharm Assoc (2003). 2005; 45 (4):466-72. Epub 2005/09/01. PMID: 16128502.
29. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2: ):CD000011. Epub 2008/04/22. doi: 10.1002/14651858. CD000011.pub3 PMID: 18425859.
30. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: A meta-analysis. Med Care. 1998; 36(8):1138-61. Epub 1998/08/26. PMID: 9708588.
31. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: A systematic review. Ann Intern Med. 2012; 157(11):785-95. Epub 2012/09/12. 1357338 [pii] doi: 10.7326/0003-4819-157-11-201212040-00538 PMID: 22964778.
32. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008; 10(5):348-54. Epub 2008/05/06. PMID: 18453793.
33. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1):67-74. Epub 1986/01/01. PMID: 3945130.
34. Culig J, Leppee M. From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol. 2014; 38(1):55-62. Epub 2014/05/24. PMID: 24851597.
35. Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003). 2011; 51(1):90-4. Epub 2011/01/21. DQL11H6140625136 [pii] doi: 10.1331/JAPhA.2011.09154 PMID: 21247831.
36. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures. Ann Pharmacother. 2006; 40 (7-8):1280-88. Epub 2006/07/27. aph.1H018 [pii] doi: 10.1345/aph.1H018 PMID: 16868217.
37. National Collaborating Centre for Primary Care, National Institute for Health and Clinical Excellence. Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence. London 2009.